News archive
GLP‑1 news from 2012
2 dated, sourced GLP-1 developments from 2012: approvals, trial results, prices, lawsuits, compounding and culture.
- FDA & regulation
FDA approves Qsymia (phentermine/topiramate ER)
The first new weight drug in 13 years, and the most effective oral weight-loss drug for the next 14. EQUIP showed 10.9% weight loss on the 15/92 mg dose versus 1.6% on placebo at 56 weeks, with 47% of patients losing 10% or more.
- FDA & regulation
FDA approves Bydureon, the first once-weekly GLP-1
Extended-release exenatide in microspheres becomes the first GLP-1 receptor agonist that can be injected once a week rather than daily, under NDA 022200.